PCBDCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。PCBD遺伝子サイレンサーは、PCBD CRISPR/Cas9ノックアウトプラスミドとPCBDDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のPCBDCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
PCBD CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PCBD1 CRISPR/Cas9 KOプラスミド (h) | sc-417347 | h | Gene Knockout | GFP | 0 | ||
PCBD1 HDRプラスミド (h) | sc-417347-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PCBD1 Double Nickaseプラスミド (h) | sc-417347-NIC | h | Gene Knockout | Puromycin | 0 | ||
PCBD1 Double Nickaseプラスミド (h2) | sc-417347-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PCBD1 CRISPR/Cas9 KOプラスミド (m) | sc-419960 | m | Gene Knockout | GFP | 0 | ||
PCBD1 HDRプラスミド (m) | sc-419960-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PCBD1 Double Nickaseプラスミド (m) | sc-419960-NIC | m | Gene Knockout | Puromycin | 0 | ||
PCBD1 Double Nickaseプラスミド (m2) | sc-419960-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PCBD2 CRISPR/Cas9 KOプラスミド (h) | sc-413554 | h | Gene Knockout | GFP | 0 | ||
PCBD2 HDRプラスミド (h) | sc-413554-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PCBD2 Double Nickaseプラスミド (h) | sc-413554-NIC | h | Gene Knockout | Puromycin | 0 | ||
PCBD2 Double Nickaseプラスミド (h2) | sc-413554-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PCBD2 CRISPR/Cas9 KOプラスミド (m) | sc-428379 | m | Gene Knockout | GFP | 0 | ||
PCBD2 HDRプラスミド (m) | sc-428379-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PCBD2 Double Nickaseプラスミド (m) | sc-428379-NIC | m | Gene Knockout | Puromycin | 0 | ||
PCBD2 Double Nickaseプラスミド (m2) | sc-428379-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PCBD CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PCBD1 CRISPR Activationプラスミド (h) | sc-417347-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 CRISPR Activationプラスミド (h2) | sc-417347-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 Lentiviral Activation Particles (h) | sc-417347-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 Lentiviral Activation Particles (h2) | sc-417347-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 CRISPR Activationプラスミド (m) | sc-419960-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 CRISPR Activationプラスミド (m2) | sc-419960-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 Lentiviral Activation Particles (m) | sc-419960-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 Lentiviral Activation Particles (m2) | sc-419960-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 CRISPR Activationプラスミド (h) | sc-413554-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 CRISPR Activationプラスミド (h2) | sc-413554-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 Lentiviral Activation Particles (h) | sc-413554-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 Lentiviral Activation Particles (h2) | sc-413554-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 CRISPR Activationプラスミド (m) | sc-428379-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 CRISPR Activationプラスミド (m2) | sc-428379-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 Lentiviral Activation Particles (m) | sc-428379-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 Lentiviral Activation Particles (m2) | sc-428379-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |